Editorial: Exploring combination therapies for effective obesity and metabolic syndrome management

Category	Detail
Condition	Obesity and Metabolic Syndrome
Key Mechanisms	Multi-dimensional therapeutic interventions targeting hormonal pathways, microbiota modulation, and lifestyle changes.
Target Population	Adults affected by obesity and related metabolic disorders.
Care Setting	Clinical settings focusing on obesity management.

Obesity prevalence has tripled since 1975, with projections of nearly one billion adults affected by 2025.
Combination therapies targeting multiple metabolic pathways show promise for enhanced efficacy and reduced side effects.
Lifestyle interventions, such as adherence to the Mediterranean diet, can amplify pharmacological treatment effects.
Microbiota modulation presents a novel therapeutic target for obesity management.
Integrated approaches combining pharmacological, surgical, and lifestyle strategies may yield longer-lasting metabolic benefits.

Implement combination therapies that integrate pharmacological, lifestyle, and procedural interventions.

Regularly evaluate weight loss, metabolic parameters, and adherence to treatment regimens.

Monitor for potential adverse events associated with combination therapies, including muscular and hepatic effects.

Adults with obesity and comorbid metabolic conditions.

Combination therapies, including novel oral GLP-1 receptor agonists, may enhance treatment adherence and efficacy.

Adopt a holistic model of obesity care that considers biological, behavioral, and environmental factors.
Encourage patient-specific treatment regimens based on metabolic phenotype and comorbidities.
Integrate behavioral strategies with pharmacological treatments for sustainable obesity management.

Clinical Scorecard: Investigating Combined Treatment Approaches for Effective Management of Obesity and Metabolic Syndrome